Stay up to date with news and events
Self-determination on the HD journey: the role of Advanced Care Planning
December 4, 2024
Here, we cover a report on Advanced Care Planning (ACP) prepared by clinical researchers at the University College London, reminding us there are things that…
Giving Thanks to the Huntington’s Disease Family Community for Advancing Research
In the spirit of gratitude, this Giving Tuesday, the HDBuzz editorial team would like to reflect on the unique and transformative role the Huntington’s disease…
2024 HDBuzz Prize: Beyond nerve cells – who are the other players in the HD brain?
November 27, 2024
A new study led by researchers from Columbia University used postmortem brain samples to show that a special type of brain cell, called astrocytes, may…
Face-to-face: Huntington’s disease families are heard by the FDA
November 23, 2024
TRIGGER WARNING: This article contains a frank discussion around the challenges and realities of living with Huntington’s disease, as well as caring for those affected…
The dust has settled: Sage’s dalzanemdor won’t advance for cognitive impairment
November 22, 2024
The Huntington’s disease (HD) community received the news on November 20, 2024 that Sage Therapeutics would be halting the development of their drug dalzanemdor (previously…